Sana Biotechnology, Inc.
Engineering cells as medicine to repair genes and treat cancer, diabetes, and autoimmune disorders.
SANA | NDAQ
Overview
Corporate Details
- ISIN(s):
- US7995661045
- LEI:
- Country:
- United States of America
- Address:
- 188 EAST BLAINE STREET, SUITE 400, 98102 SEATTLE
- Website:
- https://sana.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Sana Biotechnology, Inc. is a clinical-stage company focused on creating and delivering engineered cells as medicines. The company develops both *ex vivo* (cells modified outside the body) and *in vivo* (cells modified inside the body) cell engineering platforms. Its core mission is to repair and control genes or replace damaged cells to address the underlying causes of a broad range of diseases. Sana is advancing a pipeline of therapeutic candidates targeting serious conditions, including cancer, diabetes, and various autoimmune disorders, with the ultimate goal of providing accessible and curative treatments for patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Sana Biotechnology, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Sana Biotechnology, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Sana Biotechnology, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
